Full Text Journal Articles by
Author Ching Y Voss


Find full text journal articles

Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis.

Ching Y Voss, Terry J Fry, Max J Coppes, Morris A Blajchman,

Most of the current cell-based immunotherapy protocols concentrate on immune stimulatory effects against certain pathogenic insults, such as cancer. In this article, a potential cell-based immunotherapeutic strategy to induce immune tolerance by infusion of apoptotic leukocytes is presented in conjunction with a review of newly understood mechanisms of action of ... Read more >>

Transfus Med Rev (Transfusion medicine reviews)
[2010, 24(1):22-32]

Cited: 14 times

View full text PDF listing >>

Adolescent presentation of x-linked lymphoproliferative disease.

Samuel L Friedlander, Kevin T Dooms, Christine M Seroogy, Ching Y Voss, William A Agger, Kejian Zhang, Jack Bleesing, Alexandra H Filipovich,

Ann Allergy Asthma Immunol (Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology)
[2008, 100(4):398-400]

Cited: 0 times

View full text PDF listing >>


Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27/CD70 interactions.

Sara Deola, Monica C Panelli, Dragan Maric, Silvia Selleri, Natalia I Dmitrieva, Ching Y Voss, Harvey Klein, David Stroncek, Ena Wang, Francesco M Marincola,

CD8-expressing cytotoxic T cell (CTL) interactions with APCs and helper T cells determine their function and ability to survive. In this study, we describe a novel interaction independent of Ag presentation between activated CTLs and bystander CD19-expressing B lymphocytes. Ag-stimulated CTLs serially engage autologous B lymphocytes through CD27/CD70 contact that ... Read more >>

J Immunol (Journal of immunology (Baltimore, Md. : 1950))
[2008, 180(3):1362-1372]

Cited: 37 times

View full text PDF listing >>

Dendritic cell-based immunotherapy for cancer and relevant challenges for transfusion medicine.

Ching Y Voss, Mark R Albertini, James S Malter,

The encouraging results from dendritic cell-related cancer immunotherapy have created tremendous interest for its broad clinical application. Dendritic cells are the most potent antigen-presenting cells. In cancer patients, dendritic cell production and function along with other antitumor immune defenses are compromised. Autologous dendritic cells enriched and sensitized in vitro with ... Read more >>

Transfus Med Rev (Transfusion medicine reviews)
[2004, 18(3):189-202]

Cited: 3 times

View full text PDF listing >>



0.4731 s